Texoma Cancer Center — Wichita Falls, Texas

Texoma Cancer Center is a clinical research site located in Wichita Falls, Texas, United States 76310.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Texoma Cancer Center has participated in 9 clinical trials.

Therapeutic areas: Breast Cancer, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer.

Sponsors: NSABP Foundation Inc, Novartis Pharmaceuticals, Eisai Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wichita Falls

Browse all research sites in Texas · View every site in Wichita Falls

• Grayline Clinical Drug Trials
• Grayline Research Center
• Research Site
• Texas Oncology-Wichita Falls Texoma Cancer Center
• Digestive Health Research of North Texas
• GSK Investigational Site
• Pfizer Investigational Site
• Clarke Eyecare Center
• Alcon Investigator 8028
• Texas Oncology West Texas
• Wichita Falls Heart Clinic

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texoma Cancer Center?

Texoma Cancer Center has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texoma Cancer Center conducted?

Texoma Cancer Center has 9 clinical trials on record. Their work covers Breast Cancer, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer.

Is Texoma Cancer Center accredited by Crixeo Clinical Trials?

Texoma Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texoma Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.